Appointment booking for Dr. James Fischkoff, MD is currently not available.Dr. James Fischkoff, MD has not yet fully activated their profile on DiabetesIQ.
Dr. James Fischkoff, MD (he/him) is a Rheumatologist in Freehold, NJ with over 13 years of experience. What is your opinion of Dr. James Fischkoff, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 13 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. James Fischkoff, MD has received over $15,394 which includes payments from the following companies:
$6,869.19 from Janssen Research & Development, LLC
$2,471.33 from Horizon Pharma plc
$1,874.70 from Amgen Inc.
$1,563.21 from UCB Biosciences Inc.
$1,367.06 from Pfizer Inc.
$339.72 from Novartis Pharmaceuticals Corporation
$247.55 from AbbVie, Inc.
$137.47 from GENZYME CORPORATION
$136.47 from Janssen Biotech, Inc.
$103.41 from Genentech USA, Inc.
$79.84 from GlaxoSmithKline, LLC.
$55.00 from sanofi-aventis U.S. LLC
$42.04 from Questcor Pharmaceuticals
$34.02 from UCB, Inc.
$25.14 from DePuy Synthes Sales Inc.
$15.00 from E.R. Squibb & Sons, L.L.C.
$11.53 from Ferring Pharmaceuticals Inc.
$11.11 from Mallinckrodt LLC
$10.58 from Horizon Pharma USA, Inc.
Payments received by Dr. James Fischkoff, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!